Abbvie Overview
Abbvie Target Price
Analysts' average 12-month price target for Abbvie is $290.
Get informed when a big investor buys or sells
+ FollowShare Price
$262.58
Average Target Price
$287.11
9.3% upside
9.3% upside18 analysts in the last 4 months
High: $315 | Low: $260
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-09-10 | HSBCRajesh Kumar | $315 | 20% upside |  |
| 2026-08-20 | Piper Sandler | $303 | 15.4% upside | |
| 2026-08-17 | Wells Fargo | $300 | 14.3% upside | |
| 2026-08-13 | Wolfe ResearchAlexandria Hammond | $300 | 14.3% upside | |
| 2026-08-04 | Guggenheim | $288 | 9.7% upside | |
| 2026-08-03 | Morgan Stanley | $296 | 12.7% upside | |
| 2026-08-03 | Canaccord GenuityGary Nachman | $290 | 10.4% upside | |
| 2026-07-29 | Barclays | $300 | 14.3% upside | |
| 2026-07-22 | Canaccord Genuity | $282 | 7.4% upside | |
| 2026-07-13 | UBS | $260 |  1% downside | |
| 2026-07-13 | BMO Capital | $300 | 14.3% upside | |
| 2026-07-10 | RBC CapitalTrung Huynh | $280 | 6.6% upside | |
| 2026-07-10 | Wells Fargo | $295 | 12.3% upside | |
| 2026-07-09 | Guggenheim | $261 | 0.6% downside | |
| 2026-07-06 | HSBC | $300 | 14.3% upside | |
| 2026-07-06 | Cantor Fitzgerald | $265 | 0.9% upside | |
| 2026-06-23 | Canaccord Genuity | $273 | 4% upside | |
| 2026-06-22 | Wells Fargo | $260 | 1% downside | |
| 2026-05-15 | Evercore ISI | $235 | 10.5% downside | |
| 2026-05-14 | Piper Sandler | $298 | 13.5% upside | |
| 2026-04-30 | Morgan Stanley | $278 | 5.9% upside | |
| 2026-04-23 | Piper Sandler | $294 | 12% upside | |
| 2026-04-20 | Canaccord Genuity | $262 | 0.2% downside | |
| 2026-04-10 | GuggenheimVamil Divan | $249 | 5.2% downside | |
| 2026-04-08 | Cantor Fitzgerald | $240 | 8.6% downside | |
| 2026-02-24 | RBC CapitalTrung Huynh | $260 | 1% downside | |
| 2026-02-19 | Barclays | $275 | 4.7% upside | |
| 2026-02-18 | Piper Sandler | $299 | 13.9% upside | |
| 2026-02-05 | UBS | $230 | 12.4% downside | |
| 2026-02-04 | Evercore ISIGavin Clark-Gartner | $228 | 13.2% downside | |
| 2026-01-28 | Goldman SachsAsad Haider | $223 | 15.1% downside | |
| 2026-01-20 | Berenberg Bank | $275 | 4.7% upside | |
| 2026-01-15 | BMO CapitalEvan David Seigerman | $258 | 1.7% downside | |
| 2026-01-07 | UBS | $240 | 8.6% downside | |
| 2025-12-12 | Morgan Stanley | $269 | 2.4% upside | |
| 2025-12-10 | HSBC | $265 | 0.9% upside | |
| 2025-11-05 | Piper SandlerDavid Amsellem | $289 | 10.1% upside | |
| 2025-11-03 | Raymond JamesGary Nachman | $256 | 2.5% downside | |
| 2025-10-20 | Guggenheim | $242 | 7.8% downside | |
| 2025-10-17 | Raymond JamesGary Nachman | $250 | 4.8% downside | |
| 2025-10-10 | Piper Sandler | $284 | 8.2% upside | |
| 2025-10-09 | Cantor Fitzgerald | $250 | 4.8% downside | |
| 2025-10-03 | UBS | $251 | 4.4% downside | |
| 2025-10-02 | HSBC | $225 | 14.3% downside | |
| 2025-09-15 | Cantor FitzgeraldCarter Gould | $245 | 6.7% downside | |
| 2025-02-03 | Raymond JamesGary Nachman | $220 | 16.2% downside | |
| 2025-02-03 | BMO CapitalEvan Seigerman | $215 | 18.1% downside | |
| 2024-11-12 | BMO CapitalEvan David Seigerman | $208 | 20.8% downside | |
| 2024-10-31 | BMO CapitalEvan David Seigerman | $228 | 13.2% downside | |
| 2024-10-31 | Bank of America SecuritiesCharlie Yang | $210 | 20% downside | |